Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-002454

Options or other derivatives

  • Chief Scientific Officer acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Loose Christopher R. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2023-01-26 Grant or award : show line 1 in the form Restricted Stock Unit +105,000 105,000 105,000 D
Loading xslF345X03/form4.xml…